Clinical Trials at Connecticut Children's Medical Center
As of September 2026, 54 paid clinical trials are recruiting at Connecticut Children's Medical Center, located at 282 WASHINGTON ST, HARTFORD, CT 06106-3322, phone (860) 545-8557 in Hartford, Connecticut. Active studies at this site cover conditions such as Neuroblastoma, Degenerative Disc Disease and Breast Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
54 clinical trials at Connecticut Children's Medical Center
·Clear filters·A Study to Assess Growth in Children With Idiopathic Short Stature
A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
Easing Scan Anxiety in Pediatric Oncology Caregivers Through Meditation-based Programs
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Interoceptive Awareness and Function in Adolescents With Chronic Pain
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
Project: Every Child for Younger Patients With Cancer
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Digoxin Medulloblastoma Study
A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
Assessment and Educational Intervention to Reduce Ultra-processed Food Consumption in Pediatric Patients With IBD
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Genomically Profiling, Collecting, Archiving and Distributing Hematologic Malignancy Specimens
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)
Common conditions studied in Hartford
- Neuroblastoma (8 active studies)
- Degenerative Disc Disease (6 active studies)
- Breast Cancer (5 active studies)
- Sickle Cell Disease (5 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (4 active studies)
- Coronary Artery Disease (4 active studies)
Leading research sponsors in Hartford
- National Cancer Institute (NCI)
- Children's Oncology Group
- Connecticut Children's Medical Center
- SWOG Cancer Research Network
- Memorial Sloan Kettering Cancer Center
Frequently asked questions
How many paid clinical trials are currently recruiting in Hartford?
There are approximately 232 recruiting clinical trials in Hartford, Connecticut listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Hartford pay participants?
Most recruiting trials in Hartford compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Hartford?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Hartford?
The most common conditions under active study in Hartford include Neuroblastoma (8), Degenerative Disc Disease (6), Breast Cancer (5), Sickle Cell Disease (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Hartford?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Hartford on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Hartford?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Hartford?
Recruiting research sites in Hartford include Connecticut Children's Medical Center, Hartford Hospital, Smilow Cancer Hospital Care Center at Saint Francis, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Hartford right now?
The largest active categories in Hartford are Cancer & tumors (94), Cardiovascular (16), Neurology & pain (12). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Connecticut Children's Medical Center?
Connecticut Children's Medical Center is located at 282 WASHINGTON ST, HARTFORD, CT 06106-3322. Use the Google Maps link in the intro above to get directions.
How do I contact Connecticut Children's Medical Center?
You can reach Connecticut Children's Medical Center by phone at (860) 545-8557. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.